Category Archives: Pharmaceuticals & Biotech
Neurostimulation Devices Market Insights The leading companies in the neurostimulation devices landscape include Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, and LivaNova, which collectively held a market share of approximately 65-70% in 2024. These companies focus on innovation pipelines that … Continue reading
Active Implantable Medical Devices Market Insights Leading companies operating in the active implantable medical devices market include Medtronic, Abbott, and Cochlear Ltd., all of which are actively pursuing technical innovations and strategic acquisitions to expand their market footprint. The global … Continue reading
Osteoporosis – Pipeline Insight, 2026 There are 30+ key companies, including Alvotech, Transcenta Holding, GlycoNex, and others, developing therapies for Osteoporosis across multiple stages of clinical development. The competitive landscape is characterized by a focus on novel monoclonal antibodies, biosimilars, … Continue reading
Traumatic Brain Injury (TBI) – Pipeline Insight, 2026 There are 20+ key companies, including Oragenics, SHINKEI Therapeutics, AlzeCure, Algernon Pharmaceutical, and others, developing therapies for Traumatic Brain Injury. The current treatment landscape relies on managing symptoms with off-label medications, meaning … Continue reading
DelveInsight’s “Glucagon-Like Peptide Agonist Pipeline Insight 2026” report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in the Glucagon-Like Peptide Agonist pipeline landscape. It covers the Glucagon-Like Peptide Agonist Pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading
Science Knows No Borders: How Does WuXi AppTec Empower Innovation Across Regions
Since its founding in 2000, WuXi AppTec’s mission has remained constant: to help global customers and partners discover, develop, and manufacture pharmaceuticals and healthcare products to benefit patients in need. Over the past 25 years, WuXi AppTec has partnered with … Continue reading
DelveInsight’s “Autism Spectrum Disorder Pipeline Insight 2026” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in the Autism Spectrum Disorder pipeline landscape. It covers the Autism Spectrum Disorder Pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading
DelveInsight’s “Ulcerative Colitis Pipeline Insight 2026” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in the Ulcerative Colitis Pipeline Landscape. It covers the Ulcerative Colitis pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading
Fabry Disease Market Estimated at USD 1.7 Billion in 2024, Reports DelveInsight
Fabry Disease Market Leading organizations engaged in the Fabry disease domain include Freeline Therapeutics, 4D Molecular Therapeutics, Idorsia Pharmaceuticals, Protalix Biotherapeutics, Sanofi Genzyme, Sangamo Therapeutics, GREENOVATION BIOTECH GMBH, Shire, Takeda, Amicus Therapeutics, Protalix, uniQure, Codexis, MP6 Therapeutics, CellGenTech, and several … Continue reading
Hunter Syndrome Market The major companies operating in the Hunter Syndrome space include Homology Medicine, Denali Therapeutics, Regenxbio, Takeda, JCR Pharmaceuticals, GC Pharma, Sangamo Therapeutics, ArmaGen, and others. In 2023, the United States represented the largest share of the Hunter … Continue reading
